Table 3.
2001 | 2004 | 2009 | ||||
---|---|---|---|---|---|---|
n | % | n | % | n | % | |
FGAs | ||||||
Haloperidol | 690 | 28.8 | 387 | 18.1 | 412 | 18.5 |
Chlorpromazine | 561 | 23.4 | 349 | 16.3 | 251 | 11.3 |
Sulpiride | 232 | 9.7 | 178 | 8.3 | 129 | 5.8 |
Fluphenzine decanoate | 112 | 4.7 | 38 | 1.8 | 66 | 3.0 |
Flupentixol decanoate | 95 | 4.0 | 52 | 2.4 | 85 | 3.8 |
SGAs | ||||||
Risperidone | 472 | 19.7 | 631 | 29.5 | 689 | 31.0 |
Clozapine | 348 | 14.5 | 340 | 15.9 | 331 | 14.9 |
Olanzapine | 114 | 4.8 | 226 | 10.6 | 352 | 15.8 |
Quetiapine | 86 | 3.6 | 167 | 7.8 | 226 | 10.2 |
Aripiprazole | 0 | 0 | 0 | 0 | 113 | 5.1 |
Antidepressants | ||||||
Fluoxetine | 28 | 1.2 | 27 | 1.3 | 27 | 1.2 |
Fluvoxamine | 14 | 0.6 | 17 | 0.8 | 40 | 1.8 |
Trazodone | 12 | 0.5 | 38 | 1.8 | 34 | 1.5 |
Paroxetine | 8 | 0.3 | 17 | 0.8 | 11 | 0.5 |
Sertraline | 5 | 0.2 | 9 | 0.4 | 30 | 1.3 |
%, percentage of all patients; FGA, first-generation antipsychotic; SGA, second-generation antipsychotic.